Publications To Date


    Filter Publications

    PAGE 5 OF 87 | DISPLAYING 61 - 75 OF 1293 RESULTS

    Sourbier C et al., Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc., , Sci Rep, Dec 05, 2019

    Wang Z et al., Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4., , Nat Commun, Dec 05, 2019

    Baldovini C et al., Approaches to Tumor Classification in Pulmonary Sarcomatoid Carcinoma., , Lung Cancer (Auckl), Dec 05, 2019

    Tekpli X et al., An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment., , Nat Commun, Dec 03, 2019

    Chhatriya B et al., Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis., , BMC Cancer, Dec 03, 2019

    You BH et al., HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2, , Proc Natl Acad Sci U S A., Dec 03, 2019

    Alì G et al., A gene-expression-based test can outperform bap1 and p16 analyses in the differential diagnosis of pleural mesothelial proliferations., , Oncol Lett, Dec 02, 2019

    Phuoc V et al., Drug therapy for double-hit lymphoma., , Drugs Context, Dec 02, 2019

    Chornoguz O et al., Characterization of a Novel Bispecific Antibody That Activates T Cells In Vitro and Slows Tumor Growth In Vivo., , Monoclon Antib Immunodiagn Immunother, Dec 01, 2019

    Baek DW et al., High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer., , J Cancer Res Clin Oncol, Nov 28, 2019

    Bodor C et al., Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma., , J Neuropathol Exp Neurol, Nov 28, 2019

    Croce S et al., The NanoCind® signature is an independent prognosticator of recurrence and death in uterine leiomyosarcomas., , Clin Cancer Res, Nov 26, 2019

    Steinmann S et al., DAPK1 loss triggers tumor invasion in colorectal tumor cells., , Cell Death Dis, Nov 26, 2019

    Creed JH et al., Commercial gene expression tests for prostate cancer prognosis provide paradoxical estimates of race-specific risk, , Cancer Epidemiol Biomarkers Prev, Nov 22, 2019

    Barrow-McGee R et al., Real‐time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study, , J Pathol., Nov 22, 2019